Browse the corpus

Loratadine is a widely utilized second-generation antihistamine prescribed for the management of allergic rhinitis and urticaria, conditions that frequently disrupt daily functioning and quality of life. Its selective action on peripheral H1 receptors helps reduce symptoms such as sneezing, itching, and rhinorrhea while limiting sedative effects. This activity reviews the clinical applications of loratadine, including its mechanism of action, contraindications, dosing recommendations across patient groups, pharmacokinetic characteristics, potential adverse reactions, and essential drug interaction considerations. A clear understanding of these principles enables clinicians to prescribe loratadine safely and effectively. This activity also highlights the essential role of the interprofessional healthcare team in ensuring optimal use of loratadine. Collaborative practice supports accurate medication reconciliation, comprehensive patient counseling, and ongoing monitoring, particularly for individuals with hepatic or renal impairment or those at elevated risk for medication-related complications. By applying evidence-based guidance, clinicians can enhance treatment precision, reduce the likelihood of adverse events, and improve therapeutic outcomes. Through coordinated and informed care, healthcare professionals can promote the safe and effective integration of loratadine into patient management plans. Objectives: Assess renal and hepatic function in patients before initiating loratadine therapy. Identify potential adverse effects and implement strategies to minimize loratadine-related toxicity. Implement safe administration techniques for different loratadine formulations, including tablets, orally disintegrating tablets, capsules, and syrup. Collaborate with interprofessional team members to optimize loratadine therapy and improve outcomes in allergic rhinitis and urticaria. Access free multiple choice questions on this topic.

Signs and Symptoms of Overdose Loratadine-induced cardiotoxicity, including cardiac arrhythmias and QT-interval prolongation, is possible in patients, particularly in older patients, who take more than the recommended daily dose. Though rare, overdosing on loratadine may cause significant toxicity, including agitation and symptoms of anticholinergic syndrome. Symptoms include, but are not limited to, mydriasis, urinary retention, tachycardia, and skin flushing.[49][50][51] Management of Overdose Treatment protocol for loratadine toxicity involves supportive care, supplemental oxygen, and cardiac monitoring. Standard ACLS guidelines should be followed. If the patient develops torsades de pointes, loratadine should be discontinued. The management of patients with drug-induced TdP includes identifying and withdrawing the offending drug, replenishing the electrolytes, and infusing intravenous (IV) magnesium. In resistant cases, temporary cardiac pacing may be required to increase the heart rate.[52] The ingestion of 300 mg of loratadine by a child aged 6 resulted in a slight increase in blood pressure and heart rate, which has been managed with supportive care.[53] Adults with symptoms of anticholinergic poisoning due to loratadine toxicity may receive physostigmine antidote therapy (recommended dose is between 0.5 and 2 mg IV). Antidote therapy should be supervised exclusively by a medical toxicologist. There is no evidence of abuse potential or dependency with loratadine.

Loratadine is an effective and safe medication for alleviating symptoms of allergic rhinitis and treating urticaria. The drug is available OTC; therefore, it is essential for pharmacists to educate patients on the therapeutic dose and review their medication profile for potential interactions. The primary care clinician (MD, DO, PA, NP) must counsel the patient on the importance of reading labels to avoid taking more than the recommended dose to reduce the risk of drug-related toxicities. Although loratadine is a relatively safe drug, healthcare providers should inform patients of all potential adverse drug reactions associated with the medication, and medication reconciliation is necessary when adding or discontinuing any drug. A pragmatic trial showed that medication reconciliation, even when done as part of routine clinical practice, significantly reduces the risk of clinically significant medication errors at hospital discharge.[54] Healthcare providers should also assess liver and kidney function before prescribing medication to individuals with hepatic or renal impairment. Nurses should take a complete medication history from the patient at each visit, including OTC agents and supplements, and chart these so all interprofessional healthcare team members have comprehensive patient information. Nursing staff can also reinforce counseling to the patient on proper dosing and administration of loratadine, as well as watch for adverse effects and patient compliance. Pharmacists can reinforce dosing and administration parameters and check for drug-drug interactions. In an overdose, emergency physicians should rapidly stabilize the patient. A psychiatric consultation is required if the overdose is intentional.[55] An interprofessional team approach and effective communication among physicians, advanced practice providers, pharmacists, and nurses are crucial to minimizing potential adverse effects and enhancing patient outcomes related to loratadine therapy.